Research Article
Preparation, Characterization, and Preliminary Imaging Study of [188Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis
Table 3
The biodistribution of [188Re]ReO4- in mice (n = 4).
| Tissue | %ID/g (%) | 1 h | 3 h | 6 h | 24 h | 48 h |
| Heart | 1.422 ± 0.339 | 0.401 ± 0.050 | 0.176 ± 0.074 | 0.017 ± 0.005 | 0.011 ± 0.004 | Liver | 2.480 ± 0.556 | 0.530 ± 0.038 | 0.258 ± 0.086 | 0.023 ± 0.010 | 0.018 ± 0.010 | Spleen | 2.341 ± 0.973 | 0.490 ± 0.090 | 0.270 ± 0.098 | 0.028 ± 0.007 | 0.022 ± 0.006 | Lung | 4.458 ± 1.379 | 1.026 ± 0.312 | 0.487 ± 0.132 | 0.054 ± 0.017 | 0.036 ± 0.008 | Kidney | 2.923 ± 0.658 | 0.683 ± 0.118 | 0.338 ± 0.191 | 0.017 ± 0.003 | 0.017 ± 0.007 | Stomach | 22.747 ± 5.67 | 8.578 ± 3.928 | 2.828 ± 1.287 | 0.053 ± 0.032 | 0.029 ± 0.012 | Thyroid gland | 20.247 ± 2.489 | 10.167 ± 1.618 | 4.299 ± 1.015 | 0.051 ± 0.026 | 0.025 ± 0.009 | Small intestine | 1.671 ± 0.448 | 0.558 ± 0.207 | 0.263 ± 0.050 | 0.023 ± 0.004 | 0.014 ± 0.005 | Blood | 4.648 ± 1.631 | 1.578 ± 0.419 | 0.533 ± 0.254 | 0.023 ± 0.009 | 0.007 ± 0.002 | Brain | 0.207 ± 0.044 | 0.070 ± 0.024 | 0.044 ± 0.019 | 0.017 ± 0.004 | 0.013 ± 0.006 | Femur | 1.670 ± 0.345 | 0.431 ± 0.038 | 0.213 ± 0.102 | 0.031 ± 0.003 | 0.011 ± 0.005 | Muscle | 0.775 ± 0.074 | 0.182 ± 0.023 | 0.109 ± 0.065 | 0.021 ± 0.008 | 0.020 ± 0.005 | Gonad | 1.096 ± 0.007 | 0.404 ± 0.130 | 0.207 ± 0.065 | 0.021 ± 0.009 | 0.007 ± 0.001 | Femur/heart | 1.195 | 1.075 | 1.205 | 1.853 | 1.060 | Femur/liver | 0.685 | 0.813 | 0.823 | 1.325 | 0.638 | Femur/muscle | 2.193 | 2.372 | 1.950 | 1.498 | 0.585 |
|
|
The percentage injection dose rate per gram of tissue (%ID/g) is expressed as mean ± standard deviation ( ± s). |